Have Changing Liability Rules Compensated Workers Twice for Occupational Hazards? Earnings Premiums and Cancer Risks

Posted: 21 Sep 1999

See all articles by John R. Lott

John R. Lott

Crime Prevention Research Center

Richard L. Manning

Pfizer, Inc.

Abstract

During the last couple of decades courts have intervened in employment relationships by allowing employees to circumvent the workers' compensation liability restrictions. Recent papers point to firms divesting themselves of operations whose employees handled dangerous substances as firms protecting themselves from these new liabilities. Supposedly, these actions prevent their workers from being justly compensated. We show that the central legal premise behind this argument is wrong. Firms cannot expose workers to hazards and then eliminate this liability by divesting or shutting down the hazardous operation. This paper also shows that workers were already being well compensated for carcinogenic exposures even before the courts started allowing workers to collect large damages for occupational illnesses. Instituting the new liability rules also coincided with a large drop in earnings premiums. The compensation for carcinogenic exposures implies values of life that are comparable to studies examining other occupational risks. Our best estimate is $6 million in 1984 dollars, with a range of 1.2 to $12 million. The large premiums imply that workers who were employed prior to the legal changes received court awards which essentially compensated them a second time for their misfortune.

JEL Classification: J28

Suggested Citation

Lott, John R. and Manning, Richard L., Have Changing Liability Rules Compensated Workers Twice for Occupational Hazards? Earnings Premiums and Cancer Risks. Journal of Legal Studies, Vol. 29, No. 1, Part 1, January 2000, Available at SSRN: https://ssrn.com/abstract=181830

John R. Lott (Contact Author)

Crime Prevention Research Center ( email )

PO Box 2293
1100 W Kent Ave
Missoula, MT 59801
United States

Richard L. Manning

Pfizer, Inc.

235 East 42 Street
New York, NY 10017
United States
212-573-5709 (Phone)

Do you have negative results from your research you’d like to share?

Paper statistics

Abstract Views
1,687
PlumX Metrics